leisure time -WSS

leisure time

author：hotspot 2025-10-02 20:53:02 - browse：8455

Venture capital firm RA Capital is starting a new incubator, setting the stage for the firm to create new startups over the next several years that hone in on synthetic biology, a long-gestating field that insiders say is getting renewed interest.

The Boston-based VC’s incubator is called RASyn, and will be led by Robert Nicol, according to people familiar with the firm’s plans. Nicol spent more than 20 years at the Broad Institute, where he co-founded the MIT-Broad Foundry for Synthetic Biology, as well as HiFiBio Therapeutics and Design Pharmaceuticals.

RA Capital confirmed RASyn’s existence. Senior Managing Director Josh Resnick told STAT it’s part of the firm’s work to rethink how it develops platforms — core technologies or scientific approaches that underpin all of the drugs a biotech develops — but declined to comment further.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Amazon on where the company's health care bets are headed next

WSS

In 'major milestone,' FDA approves first cell therapy for solid tumors

A new House health package & hospitals’ new site

Researchers tackle phage therapy hurdles for wider adoption

The (many) problems with a new study criticizing cancer screening

How to fix cancer clinical trials' diversity problem

A rare thyroid diagnosis led to unexpected, all

leisure time

leisure time

Wikipedia

Cancer drug shortages should be causing more outrage

Illumina names Agilent executive as new CEO

United colonoscopy coverage change 'may cost lives,' doctors say

How to fix cancer clinical trials' diversity problem

Anesthesiologist group: stop taking Ozempic before surgery

New CMS data security rules will hurt Medicare, Medicaid research

Affirmative action in medical school literally saved lives

MD Anderson's Padmanee Sharma responds to research credit suit

Alkermes shareholders re

Weight loss drugs aren’t covered by Obamacare. That may change

hotspot

Researchers tackle phage therapy hurdles for wider adoption

Stem cell treatment guidelines are released by FDA

Reporting on presidential health from Reagan to Trump and Biden

Secretariat’s lessons for human medicine

Measles policy set amid Florida outbreak alarms vaccine proponents

Researchers tackle phage therapy hurdles for wider adoption

entertainment

focus

focus

Wikipedia